Saeed et al. followed up a population-based nationwide cohort in Norway, and found that after the adjustment of conventional risk factors, Galectin 3 was significantly associated with the risk of future coronary heart disease (CHD) and may help to predict the occurrence of CHD in patients with T1D [64]. This evidence concerns the gene LGALS3 and coronary artery disorder.